CP


Exclusive Digital Edition eBook


CP

Cell & Gene Therapy Outsourcing Trends

Cell and gene therapies represent the next-generation of therapeutics. While still in a niche stage, the cell and gene therapy market—valued at nearly $4.39 billion in 2020—is poised for rapid growth and predicted to reach nearly $35 billion in 2030. In addition, roughly 12% of today’s clinical pipeline products and at least 16% of preclinical pipeline products are cell and gene therapies. At the same time, pharmaceutical service providers are ramping up activities to meet the demands of the sector. These ambitious contract development and manufacturing organizations (CDMOs) are pioneering a new industry serving the emerging cell and gene therapy space.

Fill out my online form.